Phoenix BioPharm is a Specialty Pharma company that was established to bring to market re-profiled therapeutics for the treatment of Central Nervous System (CNS), Cardiovascular (CVD) Diseases, and specialty products. Phoenix BioPharms re-profiling approach entails developing the optimal therapeutic profile for each of its acquired products in order to maximize market penetration and generate market expansion. This will be accomplished through developing novel indications, improving product quality and formulations, and targeting sub-populations. Phoenix BioPharm will identify and acquire products that have large market potential, with clinical and market differentiation from current alternatives.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
